Kintara Therapeutics Inc. Skyrocketed
Mon, Apr 11, 2022 at 05:30 PM
Kintara Therapeutics Inc. (KTRA:NASDAQ) shot up at $0.5, representing a gain of 35.4%. On Fri, Apr 08, 2022, KTRA:NASDAQ hit a New 2-Week Low of $0.37. The stock got featured on our News Catalysts scanner on Mon, Apr 11, 2022 at 02:45 PM in the 'BIOTECH' category. From Mon, Mar 28, 2022, the stock recorded 33.33% Up Days and 20.00% Green Days
The stock spiked on Tue, Oct 19, 2021 at $1.1 with a volume of 12M+, and its share price has been moving sideways in recent weeks.
About Kintara Therapeutics Inc. (KTRA:NASDAQ)
Kintara Therapeutics Inc is engaged in the development of novel cancer therapies for patients with unmet medical needs.
Top 10 Gainers:
- Veru Inc. (VERU:NASDAQ), 182.3%
- Hoth Therapeutics, Inc. (HOTH:NASDAQ), 71.57%
- Athersys, Inc. (ATHX:NASDAQ), 63%
- Altamira Therapeutics Ltd. (CYTO:NASDAQ), 55.14%
- Genocea Biosciences, Inc. (GNCA:NASDAQ), 50%
- Kintara Therapeutics Inc. (KTRA:NASDAQ), 35.41%
- 21Vianet Group, Inc. (VNET:NASDAQ), 29.63%
- SailPoint Technologies Holdings, Inc. (SAIL:NYSE), 29.16%
- Reading International, Inc. (RDIB:NASDAQ), 25.54%
- 5E Advanced Materials Inc. (FEAM:NASDAQ), 24%